Feature | Coronavirus (COVID-19) | May 04, 2020

Practical Diagnosis and Treatment of Suspected Venous Thromboembolism During COVID-19 Pandemic

VTE therapy outlined in Journal of Vascular Surgery: Venous and Lymphatic Disorders

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of Michigan has provided an evidence-based algorithm for the treatment for venous thromboembolism (VTE) without confirmatory imaging during the pandemic. The manuscript is available online from the Journal of Vascular Surgery: Venous and Lymphatic Disorders and is freely available on the COVID-19 Collection on the Journal of Vascular Surgery (JVS) website.[1]

“The COVID-19 pandemic has caused a massive challenge to the diagnosis and treatment of positive patients at risk for VTE,” said senior author Peter K. Henke, M.D., University of Michigan. “For a variety of reasons during the crisis, the surge of patients has resulted in delays in diagnosis and therapy for these critically ill patients. Facing mounting requests for vascular ultrasounds and CT imaging, we formed an ad hoc committee of venous thrombosis experts to review our existing protocols, including that used during the H1N1 crisis, alongside current guidelines from the American College of Chest Physician and the National Institution for Health and Care Excellence."

Guidelines for Treating VTE Under COVID-19

The guideline’s key points include:
   • All patients with or suspected of COVID-19 should be treated with thromboprophylaxis.
   • Elevated D-dimer is expected with severe infection and should not be a determinant in the decision to obtain imaging. However, a negative test in combination with a low clinical score safely excludes VTE.
   • Current guidelines recommend empiric treatment for those suspected of pulmonary embolism (PE) and deep vein thrombosis (DVT) if computed tomography (CT) is delayed more than four hours and venous duplex more than 24 hours, respectively. During the pandemic, however, the benefit of empiric therapy outweighs risk even if imaging is delayed more than one month.
   • Duplex ultrasound is indicated when the following exist simultaneously:
       1. High bleeding risk,
       2. Results will change management, and
       3. Clinical suspicion for PE is high and CT unavailable or clinical suspicion for DVT is high (modified Wells and Wells scoring).
   • Most patients with confirmed or suspected VTE, not at high bleeding risk should receive therapeutic doses of anticoagulation.
   • In patients with adult respiratory distress syndrome (ARDS), low-dose heparin infusion may reduce the risk of major bleeding while protecting from thrombotic events.
   • Patients treated with low-dose anticoagulation protocols should be transitioned to full-dose anticoagulation when they are no longer in intensive care status.
   • Referral for CT or duplex may be performed upon recovery as an inpatient; however, this may be delayed to an outpatient setting in a resource-scarce environment.
   • Unilateral upper extremity limb swelling should be imaged according to the fourth guideline above.

“In this treatment paradigm, we emphasize preventing VTE-related morbidity and mortality at the expense of bleeding complications over a short term, while imaging is delayed, and also utilizing therapy that has shown benefits for other severe viral states (including H1N1),” Henke added. “With such an approach, the commitment to providing follow-up – the DVT scan that would normally be obtained in 24 hours and now will be delayed two to four weeks – must be absolute, meticulous and unwavering.”

To download the complete article, visit http://b.link/JVS-VLGuidelines.

The guideline algorithm for critically ill patients with VTE under the COVID-19 pandemic.

The guideline algorithm for critically ill patients with VTE under the COVID-19 pandemic.

 

Reference:

1. Andrea T. Obi, Geoff D. Barnes, Thomas W. Wakefield, Sandra Brown, Jonathon L. Eliason, Erika Arndt, Peter K. Henke. Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvsv.2020.04.009

Related Content

A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.

Cardiac Magnetic Resonance Imaging in Athletes With Clinical and Subclinical Myocarditis A-D, Athlete A with subclinical possible myocarditis was asymptomatic with normal electrocardiogram (ECG), echocardiogram, and high-sensitivity troponin findings. A, T2 mapping showing elevated T2 in basal-mid inferolateral wall in short axis view. B, late gadolinium enhancement (LGE) in the basal inferolateral wall in short axis view. C, Postcontrast steady state-free precession (SSFP) images showing contrast uptake in the basal-mid inferolateral wall in short axis view. D, LGE in the inferolateral wall in 3-chamber view. E-H, Athlete B with subclinical probable myocarditis was asymptomatic with normal ECG, normal echocardiogram, and elevated high-sensitivity troponin findings. E, T2 mapping showing elevated T2 in the anteroseptal wall in short axis view. F, LGE in the anteroseptal wall in 3-chamber view. G, T2 mapping showing elevated T2 in the anteroseptal wall in 3-chamber view. F, Postcontrast SSFP image showing pericardial effusion in short axis view. I-K, Athlete C with clinical myocarditis and chest pain, dyspnea, abnormal ECG, normal echocardiogram, and normal troponin findings. I, T2 mapping showing elevated T2 in the lateral wall short axis view. J, Postcontrast SSFP images showing contrast uptake in midlateral wall in short axis view. K, LGE in the epicardial midlateral wall in short axis view. L-N, Athlete D with clinical myocarditis, chest pain, abnormal ECG, echocardiogram, and troponin findings. L, T1 mapping showing elevated native T1 in midlateral wall in short axis view. M, T2 mapping showing elevated T2 in the midlateral wall in short axis view. N, LGE in the epicardial midlateral wall in short axis view. IR indicates inferior right view; IRP, inferior, right, posterior view; PLI, posterior, left, inferior view; SL, superior left view; SLA, superior, left, anterior view. Image courtesy of JAMA Cardiol. Published online May 27, 2021. doi:10.1001/jamacardio.2021.2065

News | Cardiac Imaging | June 15, 2021
June 15, 2021 — A...
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan #CT
News | Cardiac Imaging | June 14, 2021
June 14, 2021 — Heart disease and cancer are the ...
Women’s Heart Attack Research Program (HARP) shows combining OCT and cardiac MRI can detect the underlying cause of heart attack in women who did not have blocked arteries

The Women’s Heart Attack Research Program (HARP) study shows combining OCT and cardiac MRI can help detect the underlying cause of heart attacks in women who did not have blocked arteries.

News | Cardiac Imaging | November 17, 2020
November 17, 2020 — Diagnostic imaging techniques were able to find the underlying cause of heart attack in many wome
An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

News | Cardiac Imaging | September 25, 2020
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary arter
Rafael Rivero, M.D., Global Head of Medical Affairs at MSI, said: "The importance of MyoStrain cannot be understated because of the test's immense clinical value and ability to quantify intramyocardial dysfunction across 48 segments of the heart. In a six-heartbeat MRI scan, MyoStrain arms physicians with novel clinical information about a patient's heart health."
News | Cardiac Imaging | August 11, 2020
August 11, 2020 — Myocardial Solutions, Inc. and United Imaging, Inc.
The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

News | Cardiac Imaging | July 15, 2020
July 15, 2020 — ...
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Cardiac Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...